Vaccine effectiveness following routine immunization with bivalent HPV vaccine: Protection against incident genital HPV infections from a reduced-dosing schedule.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Hoes, JoskeKing, Audrey J
Schurink-van 't Klooster, Tessa M
Berkhof, Prof Johannes
Bogaards, Johannes A
de Melker, Hester E
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Vaccine effectiveness following routine immunization with bivalent HPV vaccine: Protection against incident genital HPV infections from a reduced-dosing schedule.Published in
J Infect Dis 2022; 226(4):634-643PMID
33964158ae974a485f413a2113503eed53cd6c53
10.1093/infdis/jiab250
Scopus Count
Collections
Related articles
- High Effectiveness of the Bivalent Human Papillomavirus (HPV) Vaccine Against Incident and Persistent HPV Infections up to 6 Years After Vaccination in Young Dutch Women.
- Authors: Donken R, King AJ, Bogaards JA, Woestenberg PJ, Meijer CJLM, de Melker HE
- Issue date: 2018 Apr 23
- Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors.
- Authors: Woestenberg PJ, King AJ, van Benthem BHB, Donken R, Leussink S, van der Klis FRM, de Melker HE, van der Sande MAB, Hoebe CJPA, Bogaards JA, Medical Microbiological Laboratories and the Public Health Services
- Issue date: 2018 Jan 4
- Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Trial.
- Authors: Tsang SH, Sampson JN, Schussler J, Porras C, Wagner S, Boland J, Cortes B, Lowy DR, Schiller JT, Schiffman M, Kemp TJ, Rodriguez AC, Quint W, Gail MH, Pinto LA, Gonzalez P, Hildesheim A, Kreimer AR, Herrero R, Costa Rica HPV Vaccine Trial (CVT) Group
- Issue date: 2020 Oct 1
- Bivalent Human Papillomavirus Vaccine Effectiveness in a Japanese Population: High Vaccine-Type-Specific Effectiveness and Evidence of Cross-Protection.
- Authors: Kudo R, Yamaguchi M, Sekine M, Adachi S, Ueda Y, Miyagi E, Hara M, Hanley SJB, Enomoto T
- Issue date: 2019 Jan 9
- Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects.
- Authors: Hoes J, Woestenberg PJ, Bogaards JA, King AJ, de Melker HE, Berkhof J, Hoebe CJPA, van der Sande MAB, van Benthem BHB, Medical Microbiological Laboratories and Public Health Services
- Issue date: 2021 Mar 1